Thought Leadership
Thought-provoking insights from an executive search perspective on the latest biopharma news, market shifts, and industry milestones.
An Optimistic Outlook Prevails for Innovative Biopharma Companies Despite Market & Investor Trends
While most of the funding for biotech startups developing novel therapeutics has stalled in the past year as VCs take a more conservative approach and focus on companies already generating revenue through multiple streams, demand for therapies has not decreased.
Adapting and Evolving in a Volatile Market: Cell Therapy and Rare Disease Developments
If there’s one thing that remains constant in biotech, it’s the ability of companies to adapt and evolve relative to available resources and current limitations….
In a Down Market for Biotech, Microbiome Therapeutics Could be a Safe Bet for Investors
The word ‘protein’ often makes one think of a steak dinner or a smoothie, but in the world of biotech protein therapeutics are forming the backbone of next-generation therapies and novel medicines…
JPM 2022 Highlights
With JPM 2022 having finished up last week, new standout partnerships between promising biotech companies and profitable big pharma show that reciprocity between players…
Setting Sights on Korea as a new Biotech Hub
Demographically, South Korea has been an appealing investment opportunity for pharma companies. It has a relatively large population of around 51 million people…